Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes
Open accessAbstract
MicroRNAs (miRs) regulate diverse molecular and cellular processes including oligodendrocyte (OL) precursor cell (OPC) proliferation and differentiation in rodents. However, the role of miRs in human OPCs is poorly understood. To identify miRs that may regulate these processes in humans, we isolated OL lineage cells from human white matter and analyzed their miR profile. Using endpoint RT-PCR assays and quantitative real-time PCR, we demonstrate that miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human OLs. In addition, we report the expression of closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, miR-3065-3p) in both rodent and human OLs. Our findings demonstrate that miRs implicated in rodent OPC proliferation and differentiation are regulated in human OLs and may regulate myelination program in humans. Thus, these miRs should be recognized as potential therapeutic targets in demyelinating disorders.
AI snapshot
Written from the paper’s full text.
TL;DR
This study profiles microRNA expression in human oligodendrocyte lineage cells acutely isolated from adult white matter and finds that rodent-relevant miR-219, miR-338, and miR-17-92 clusters are expressed and regulated in human oligodendrocytes. The authors propose these microRNAs as conserved regulators of human OPC proliferation/differentiation and potential therapeutic targets in demyelinating disorders.
Key findings
- miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human oligodendrocytes; miR-219 mature products were at least 5-fold enriched in white matter, miR-338-5p and miR-338-3p >15-fold enriched, and miR-17-92 members >4-fold enriched versus gray matter.
- During rodent OPC differentiation in vitro, miR-219-5p peaked at DIV5 (>6-fold higher than DIV1) and correlated with PLP expression (Pearson coefficient = 0.999, P = 0.01); miR-338-5p and miR-338-3p increased about 5-fold, while miR-3065-5p was markedly downregulated.
- In mouse brain development, miR-338-3p showed delayed upregulation (10-fold at P21 and 30-fold at P60 versus P1), and miR-17-92 members were dramatically downregulated in the first postnatal week (about 90% reduced at P7 versus P1).
- Human A2B5+ versus A2B5− oligodendrocytes showed higher miR-219 levels in A2B5+ cells; miR-338-5p, miR-1250, miR-3065-5p, and miR-657 were significantly downregulated in A2B5− cells, whereas miR-17-92 members showed no significant difference between the two populations.
Methods
- Human OL lineage cells were isolated from adult white matter surgical resections for non-tumor-related intractable epilepsy, separated by A2B5 magnetic cell sorting into A2B5+ and A2B5− fractions; four independent surgical resections were analyzed in triplicates. Rodent OPCs were cultured from postnatal day 0 Sprague-Dawley rat cortices and matured for 8 h (DIV1), 4 days (DIV5), or 7 days (DIV8).
- MicroRNA expression was measured by endpoint RT-PCR, stem-loop reverse transcription, multiplex pre-PCR, and quantitative real-time PCR normalized to 18S RNA using the 2−ΔΔCt method and qBase; western blotting was used to confirm PLP upregulation during OPC differentiation.
- Statistical comparisons used one-way ANOVA with Tukey’s post-test for developmental/culture stages and unpaired Student’s t-test for human sample comparisons.
Limitations
- Not explicitly stated in the paper; evident from the text: the study is an expression-profiling study and does not functionally manipulate these microRNAs in human OPCs/oligodendrocytes, so the proposed conserved regulatory roles remain inferential.
- The human white matter enrichment analysis used two independent samples in triplicates, and the acutely isolated human A2B5+/A2B5− comparison used four independent surgical resections, limiting broader generalizability.
- The authors note discrepancies with a prior human embryonic stem cell-derived oligodendrocyte study and attribute them to differences in sample origin and detection sensitivity; they also state that further investigation into functional contribution is needed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
7 of 26 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured
- Findingown data
The miR-338 cluster is expressed in human OLs.
“In summary, we provide the first evidence that miR-338 cluster is expressed in human OLs, as previously demonstrated in rodents (Lau et al., 2008; Dugas et al., 2010; Zhao et al., 2010).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Lau et al., 2008 source
The Results section reports miR-338 expression in oligodendrocyte-lineage cells isolated from postnatal rat brains, supporting the rodent finding attributed to Lau et al. The cited paper identifies miR-338, but the passages do not establish expression of a miR-338 cluster as a whole. The sentence presents human OL expression as the citing authors’ new finding, not as Lau et al.’s result. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites Dugas et al., 2010 source
- cites Zhao et al., 2010 source
- Rests on an assumption: In humans, the miR-338 cluster encodes six different mature miRs (miR-338-5p, miR-338-3p, miR-3065-5p, miR-3065-3p, miR-657, and miR-1250) that are encoded by four independent loci.
- Premisecitation
Over-expression of miR-219-5p, miR-338-5p, and miR-338-3p promotes rodent OPC differentiation.
“In these studies, over-expression of miR-219-5p, miR-338-5p, and miR-338-3p was shown to promote rodent OPC differentiation, indicating that these miRs play important roles during myelination (Lau et al., 2008; Budde et al., 2010; Dugas et al., 2010).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Lau et al., 2008 source
The Results section on miRNA expression reports that miR-338 increases during oligodendrocyte differentiation and miR-219 is strongly expressed in oligodendrocytes. It does not show that over-expressing these miRNAs promotes rodent OPC differentiation, or establish that effect for the specified 5p and 3p strands. The indexed passages provide no page numbers. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Budde et al., 2010 source
- cites Dugas et al., 2010 source
The Results section (‘miR-219 and miR-138 promote OL differentiation’; page unavailable) reports that a miR-219 mimic increased differentiation in purified OPCs. It also reports that miR-338 mimics had no significant effect on OL myelin-gene expression in the assays tested. Thus this paper supports the miR-219 part, but not the claim that over-expression of both miR-338 strands promotes differentiation. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Findingown data
miR-338-5p, miR-1250, miR-3065-5p, and miR-657 are significantly downregulated in the A2B5− fraction.
“Quantitative real-time RT-PCR analysis shows that all miR-338 cluster members are detectable in acutely isolate OLs and that miR-338-5p, miR-1250, miR-3065-5p, and miR-657 are significantly downregulated in the A2B5− fraction (Figure 3G).”
Quote in the paperSubstantial claim - Findingown data
Both A2B5+ and A2B5− oligodendrocytes express the three miR-219 mature products.
“Quantitative real-time RT-PCR analysis indicates that both A2B5+ and A2B5− OLs express the three miRs and that expression is downregulated as cells mature from A2B5+ to A2B5− OLs (Figure 2I).”
Quote in the paperSubstantial claim - Findingown data
miR-338-5p appears to be expressed throughout postnatal development.
“In contrast, miR-338-5p appears to be expressed throughout postnatal development.”
Quote in the paperNot a substantial claim
- Findingown data
The miR-338 cluster is expressed in the human brain.
“Endpoint RT-PCR followed by polyacrylamide gel electrophoresis showing that the miR-338 cluster is expressed in the human brain.”
Quote in the paperNot a substantial claim - Findingown data
miR-219-5p levels correlate very well with PLP expression at all time points during rat oligodendrocyte precursor cell differentiation in vitro (Pearson coefficient = 0.999, P = 0.01).
“Interestingly, miR-219-5p levels correlate very well with PLP expression at all time points (Pearson coefficient = 0.999, P = 0.01; Figure 2E).”
Quote in the paperSubstantial claim - Findingown data
miR-219-5p, miR-219-1-3p, and miR-219-2-3p are at least five times enriched in human cortical white matter compared to gray matter.
“we compared the levels of miRs 219-5p, 219-1-3p, and 219-2-3p in white and gray matter by quantitative real-time RT-PCR and found that these miRs are at least five times enriched in the white matter (Figure 2G).”
Quote in the paperSubstantial claim - Findingown data
miR-3065 shows a unique profile with significant downregulation during the first two postnatal weeks and upregulation by the third week.
“miR-3065 shows a unique profile with significant downregulation during the first two postnatal weeks and upregulation by the third week (Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
miR-338-5p, miR-1250, and miR-3065-5p are expressed in the MO3.13 cell line.
“Using this method, we found that miR-338-5p, miR-1250, and miR-3065-5p are expressed in the MO3.13 cell line whereas miR-338-5p, miR-3065-5p, and miR-657 are expressed in A2B5+ cells (Figure 3F).”
Quote in the paperSubstantial claim - Findingown data
miR-1250 and miR-657 are slightly concentrated in the white matter (2- and 3.5-fold enrichment respectively).
“miR-3065-5p and miR-3065-3p do not show any clear enrichment in either white or gray matter while miR-1250 and miR-657 are slightly concentrated in the white matter (2- and 3.5-fold enrichment respectively).”
Quote in the paperNot a substantial claim - Findingown data
Expression of the three miR-219 mature products is downregulated as cells mature from A2B5+ to A2B5− oligodendrocytes.
“Quantitative real-time RT-PCR analysis indicates that both A2B5+ and A2B5− OLs express the three miRs and that expression is downregulated as cells mature from A2B5+ to A2B5− OLs (Figure 2I).”
Quote in the paperSubstantial claim - Findingown data
Levels of some miR-338 cluster members are higher in adult human A2B5+ cells than A2B5− OLs.
“Quantitative real-time PCR showing that levels of some miR-338 cluster members are higher in adult human A2B5+ cells than A2B5− OLs.”
Quote in the paperNot a substantial claim - Findingown data
Overall expression of the miR-338 cluster increases in the mouse brain during postnatal development.
“Quantitative real-time PCR showing that overall expression of miR-338 cluster increases in the mouse brain during postnatal development.”
Quote in the paperSubstantial claim - Findingown data
All members of the miR-338 cluster except for miR-3065-5p and miR-3065-3p are enriched in human brain white matter.
“Quantitative real-time PCR showing that all members of the miR-338 cluster except for miRs 3065-5p and -3p are enriched in human brain white matter.”
Quote in the paperNot a substantial claim- Rests on an assumption: In humans, the miR-338 cluster encodes six different mature miRs (miR-338-5p, miR-338-3p, miR-3065-5p, miR-3065-3p, miR-657, and miR-1250) that are encoded by four independent loci.
- Findingown data
miR-3065-5p is highly expressed at DIV1 but markedly downregulated at DIV5.
“miR-3065-5p is highly expressed at DIV1 but markedly downregulated at DIV5.”
Quote in the paperSubstantial claim - Findingown data
miR-338-5p and miR-338-3p are highly enriched (>15-fold) in white matter tracts.
“We next used quantitative real-time RT-PCR to compare expression levels in white and gray matter and found that miR-338-5p and miR-338-3p are highly enriched (>15-fold) in white matter tracts (Figure 3E).”
Quote in the paperSubstantial claim - Findingown data
All miR-338 cluster members are detectable in acutely isolated OLs.
“Quantitative real-time RT-PCR analysis shows that all miR-338 cluster members are detectable in acutely isolate OLs and that miR-338-5p, miR-1250, miR-3065-5p, and miR-657 are significantly downregulated in the A2B5− fraction (Figure 3G).”
Quote in the paperSubstantial claim - Findingown data
miR-338-5p is more abundant than miR-338-3p from day 1 to day 8.
“Interestingly, we found miR-338-5p to be more abundant then miR-338-3p from day 1 to day 8, indicating preferential maturation of the miR located at 5′ arm of the pre-miR-338 (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
miR-3065-5p and miR-3065-3p do not show any clear enrichment in either white or gray matter.
“miR-3065-5p and miR-3065-3p do not show any clear enrichment in either white or gray matter while miR-1250 and miR-657 are slightly concentrated in the white matter (2- and 3.5-fold enrichment respectively).”
Quote in the paperNot a substantial claim - Findingown data
Relative expression analysis grouped miR-338 cluster members together.
“Interestingly, relative expression analysis grouped miR-338 cluster members together, suggesting that these miRs may be co-transcribed in human OLs (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
During maturation of the mouse brain, miR-338-3p undergoes a robust upregulation similar to that of the 219-3p miRs.
“During maturation of the mouse brain, miR-338-3p undergoes a robust upregulation similar to that of the 219-3p miRs.”
Quote in the paperSubstantial claim - Findingown data
Human oligodendrocyte lineage cells express mature products of the miR-219 locus.
“In summary, our findings provide the first evidence that human OL lineage cells express mature products of the miR-219 locus, indicating a conserved role for these miRs during human OL differentiation.”
Quote in the paperSubstantial claim - Findingown data
miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, and miR-3065-3p are expressed in both rodent and human oligodendrocytes.
“we report the expression of closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, miR-3065-3p) in both rodent and human OLs.”
Quote in the paperSubstantial claim - Findingown data
miR-219, miR-338, and miR-17-92 are enriched in human white matter.
“we demonstrate that miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human OLs.”
Quote in the paperSubstantial claim - Findingown data
miR-219-5p and miR-219-2-3p are readily detected in acutely isolated human A2B5+ cells.
“However, miR-219-5p and miR-219-2-3p were readily detected in acutely isolated human A2B5+ cells, in contrast to the previously reported in Ols derived from embryonic stem cells (Letzen et al., 2010; Figure 2H).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Letzen et al., 2010 source
Checked before — its earlier verdict is held back until a new check runs.
- Findingown data
In vitro OPC differentiation is marked by a robust upregulation (five-fold increase) of both miR-338-5p and miR-338-3p.
“Quantitative real-time RT-PCR shows that in vitro OPC differentiation is marked by a robust upregulation (five-fold increase) of both miR-338-5p and miR-338-3p (Figure 3C).”
Quote in the paperSubstantial claim - Findingown data
miR-219, miR-338, and miR-17-92 are expressed in acutely isolated human oligodendrocytes.
“we demonstrate that miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human OLs.”
Quote in the paperSubstantial claim - Findingown data
By endpoint RT-PCR followed by polyacrylamide gel electrophoresis, miR-338-5p, miR-1250, miR-3065-3p, and miR-657 are detected in human brain.
“By endpoint RT-PCR followed by polyacrylamide gel electrophoresis, we were able to detect the expression of miRs 338-5p, 1250, 3065-3p, and 657 (Figure 3D).”
Quote in the paperSubstantial claim - Findingown data
miR-17-92 members are enriched in white matter tracts when compared to gray matter (>4-fold).
“In addition, quantitative real-time RT-PCR shows that they are enriched in white matter tracts when compared to gray matter (>4-fold; Figure 4E).”
Quote in the paperNot a substantial claim - Findingnone given
Rodent-relevant miRs are also expressed by human OLs.
“In summary, our study establishes that rodent-relevant miRs are also expressed by human OLs.”
Quote in the paperSubstantial claim - Findingown data
Levels of members of the miR-17-92 cluster are downregulated during rat OPC differentiation in vitro.
“Quantitative real-time PCR showing that levels of members of the miR-17-92 cluster are downregulated during rat OPC differentiation in vitro.”
Quote in the paperSubstantial claim - Findingown data
Levels of members of the miR-17-92 cluster are dramatically downregulated during postnatal mouse brain development.
“Quantitative real-time PCR showing that levels of members of the miR-17-92 cluster are dramatically downregulated during postnatal mouse brain development.”
Quote in the paperSubstantial claim - Findingown data
Members of the miR-17-92 cluster are among the most highly expressed miRs in both rodent OPCs and mature OLs.
“The relative expression analysis, however, reveals that members of the miR-17-92 cluster are among the most highly expressed miRs in both rodent OPCs and mature OLs (Table 1).”
Quote in the paperSubstantial claim - Findingown data
miR-17-92 cluster members are dramatically downregulated within the first postnatal week in mouse brain.
“We used quantitative real-time RT-PCR to study the expression of these miRs during mouse brain development and found a dramatic downregulation within the first postnatal week, in agreement with their role in controlling OPC number (Budde et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Budde et al., 2010 source
- Findingown data
The expression profile of miR-17-92 cluster members during OPC differentiation in vitro is very similar to the profile seen in the developing mouse brain.
“In addition, the expression profile of miR-17-92 cluster members during OPC differentiation in vitro is very similar to the profile seen in the developing mouse brain (Figure 4B), suggesting that this cluster is OPC/OL enriched.”
Quote in the paperSubstantial claim - Findingown data
There is no difference in expression of miR-17-92 cluster members between human A2B5+ and A2B5− OLs.
“Quantitative real-time PCR analysis of the miR-17-92 cluster members in human A2B5+ and A2B5− OLs shows no difference in expression between the two cell types.”
Quote in the paperNot a substantial claim - Findingown data
Closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-338-3p, and miR-3065-5p) are also regulated during rodent OPC differentiation.
“Our results are in agreement with previous findings and we for the first time demonstrate that closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-338-3p, and miR-3065-5p) are also regulated during rodent OPC differentiation.”
Quote in the paperSubstantial claim - Findingown data
These miRs are the most highly expressed miRs in both precursor and mature OLs.
“Though most miR-17-92 cluster members are downregulated during OPC differentiation, relative expression analysis reveals that these miRs are the most highly expressed miRs in both precursor and mature OLs (Table 1), suggesting that these miRs might play a role in regulating levels of housekeeping transcripts in OLs.”
Quote in the paperSubstantial claim - Findingown data
Four other miRs, miR-219-1-3p, miR-219-2-3p, miR-1250, and miR-657, are enriched in white matter tracts of the human brain.
“In addition to the above-mentioned miRs, we report that four other miRs, miR-219-1-3p, miR-219-2-3p, miR-1250, and miR-657, are enriched in white matter tracts of the human brain (Figures 2G and 3E).”
Quote in the paperNot a substantial claim - Findingown data
All six miR-17-92 cluster members are readily detected in the adult human brain by endpoint RT-PCR.
“All six miR-17-92 cluster members are readily detected in the adult human brain by endpoint RT-PCR (Figure 4D).”
Quote in the paperNot a substantial claim - Findingown data
Some of these glial enriched miRs are differentially expressed by human A2B5+ and A2B5− OLs.
“In addition, we show that some of these glial enriched miRs are differentially expressed by human A2B5+ and A2B5− OLs.”
Quote in the paperSubstantial claim - Findingcitation
The current data provides evidence for the expression of miR-219, miR-338, and miR-17-92 clusters in acutely isolated-adult brain OLs in marked contrast to what was observed with human OLs derived from embryonic stem cells.
“The current data provides evidence for the expression of miR-219, miR-338, and miR-17-92 clusters in acutely isolated-adult brain OLs in marked contrast to what was observed with human OLs derived from embryonic stem cells (Letzen et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Letzen et al., 2010 source
Checked before — its earlier verdict is held back until a new check runs.
- Findingown data
No significant changes are seen for miR-17-5p and miR-18a-5p.
“No significant changes are seen for miRs 17-5p and 18a-5p.”
Quote in the paperNot a substantial claim - Findingown data
At P21, a significant upregulation from levels at P7 is seen for all miRs except miR-92a-3p.
“Intriguingly, at P21, a significant upregulation from levels at P7 is seen for all miRs except miR-92a-3p, suggesting that these miRs also play some specialized role in the postnatal brain.”
Quote in the paperSubstantial claim - Findingown data
Expression of the miR-17-92 cluster is highly upregulated in MO3.13 cells when compared with adult primary OLs.
“Quantitative real-time RT-PCR analysis revealed that expression of the miR-17-92 cluster is highly upregulated in MO3.13 cells when compared with adult primary OLs (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
miR-17-92 members are enriched in the human brain white matter.
“Quantitative real-time PCR showing that miR-17-92 members are enriched in the human brain white matter.”
Quote in the paperNot a substantial claim - Findingown data
Most miR-17-92 cluster members are downregulated during OPC differentiation.
“Though most miR-17-92 cluster members are downregulated during OPC differentiation, relative expression analysis reveals that these miRs are the most highly expressed miRs in both precursor and mature OLs (Table 1), suggesting that these miRs might play a role in regulating levels of housekeeping transcripts in OLs.”
Quote in the paperSubstantial claim - Findingown data
miR-3065-5p shows a dramatic drop in expression during the first 5 days in vitro.
“Notably, miR-3065-5p shows a dramatic drop in expression during the first 5 days in vitro, suggesting that 3065-5p might play a role in regulating OPC proliferation and/or differentiation.”
Quote in the paperSubstantial claim - Findingown data
miR-19a-3p, miR-19b-3p, miR-20a-5p, and miR-92a-3p are downregulated during rodent OPC differentiation.
“The high sensitivity of our real-time approach demonstrates that miR-19a-3p, miR-19b-3p, miR-20a-5p, and miR-92a-3p are downregulated during rodent OPC differentiation.”
Quote in the paperSubstantial claim - Findingown data
miR-19a-3p, miR-20a-5p, miR-19b-3p, and miR-92a-3p are clearly downregulated in cultured OPCs during differentiation.
“Quantitative real-time RT-PCR shows that miRs 19a-3p, 20a-5p, 19b-3p, and 92a-3p are also clearly downregulated in cultured OPCs during differentiation (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
This cluster represents one of the most highly expressed miRs in both A2B5+ and A2B5− OLs.
“This data is in agreement with the relative expression analysis revealing that this cluster represents one of the most highly expressed miRs in both A2B5+ and A2B5− OLs (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
miR-17-92 members are expressed in the human brain.
“Endpoint RT-PCR followed by polyacrylamide gel electrophoresis showing that miR-17-92 members are expressed in the human brain.”
Quote in the paperNot a substantial claim - Interpretationown data
The preferential abundance of miR-338-5p indicates preferential maturation of the miR located at the 5′ arm of the pre-miR-338.
“Interestingly, we found miR-338-5p to be more abundant then miR-338-3p from day 1 to day 8, indicating preferential maturation of the miR located at 5′ arm of the pre-miR-338 (Table 1).”
Quote in the paperSubstantial claim - Premisecitation
The role of microRNAs in human oligodendrocyte precursor cells is poorly understood.
“However, the role of miRs in human OPCs is poorly understood.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Letzen et al., 2010 source
Checked before — its earlier verdict is held back until a new check runs.
- Interpretationreasoning
The enrichment of miR-338-5p and miR-338-3p in the white matter suggests that human glial cells express these miRs.
“The enrichment of miR-338-5p and miR-338-3p in the white matter suggests that human glial cells express these miRs.”
Quote in the paperSubstantial claim - Interpretationown data
The positive and negative strands of the miR-338 locus, producing miR-338 and miR-3065, respectively, are preferentially transcribed during different stages of rodent OPC differentiation.
“These data suggest that the positive and negative strands of the miR-338 locus, producing miR-338 and miR-3065, respectively, are preferentially transcribed during different stages of rodent OPC differentiation.”
Quote in the paperSubstantial claim - Premisecitation
MicroRNAs regulate oligodendrocyte precursor cell proliferation and differentiation in rodents.
“MicroRNAs (miRs) regulate diverse molecular and cellular processes including oligodendrocyte (OL) precursor cell (OPC) proliferation and differentiation in rodents.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Emery, 2010 source
- Study design and conductown data
The RT-PCR primers yield unique amplicons (~70 nts) for every primer pair.
“we first validated the RT-PCR primers by conventional PCR followed by polyacrylamide gel electrophoresis and found unique amplicons (∼70 nts) for every primer pair (Figure 1; Table A2 in Appendix).”
Quote in the paperSubstantial claim - Interpretationown data
There is a conserved role for miR-219 during human oligodendrocyte differentiation.
“In summary, our findings provide the first evidence that human OL lineage cells express mature products of the miR-219 locus, indicating a conserved role for these miRs during human OL differentiation.”
Quote in the paperSubstantial claim - Interpretationown data
These miRs may be co-transcribed in human OLs.
“Interestingly, relative expression analysis grouped miR-338 cluster members together, suggesting that these miRs may be co-transcribed in human OLs (Table 1).”
Quote in the paperNot a substantial claim - Interpretationown data
MicroRNAs implicated in rodent oligodendrocyte precursor cell proliferation and differentiation are regulated in human oligodendrocytes.
“Our findings demonstrate that miRs implicated in rodent OPC proliferation and differentiation are regulated in human OLs and may regulate myelination program in humans.”
Quote in the paperSubstantial claim - Interpretationown data
This is the first report of the expression of miR-1250, miR-3065-5p, miR-3065-3p, and miR-657 in the human brain.
“To our knowledge, this is the first report of the expression of miRs 1250, 3065-5p, 3065-3p, and 657 in the human brain.”
Quote in the paperSubstantial claim- Rests on an assumption: miR-657 and miR-1250 are specific to humans and have not been detected in rodents.
- Interpretationown data
miR-3065-5p might play a role in regulating OPC proliferation and/or differentiation.
“Notably, miR-3065-5p shows a dramatic drop in expression during the first 5 days in vitro, suggesting that 3065-5p might play a role in regulating OPC proliferation and/or differentiation.”
Quote in the paperNot a substantial claim - Interpretationcitation
The dramatic downregulation is in agreement with their role in controlling OPC number.
“We used quantitative real-time RT-PCR to study the expression of these miRs during mouse brain development and found a dramatic downregulation within the first postnatal week, in agreement with their role in controlling OPC number (Budde et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Budde et al., 2010 source
- Interpretationcitation
Our data is consistent with previous findings showing dramatic downregulation of miR-219-5p and miR-338-5p in inactive white matter lesions in multiple sclerosis patients.
“Our data is consistent with previous findings showing dramatic downregulation of miR-219-5p and miR-338-5p in inactive white matter lesions in multiple sclerosis patients (Junker et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Junker et al., 2009 source
- Interpretationcitation
This data is consistent with the proposed role of the miR-17-92 cluster in the control of cell number.
“This data is consistent with the proposed role of the miR-17-92 cluster in the control of cell number (Budde et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Budde et al., 2010 source
- Interpretationcitation
miR-219, miR-338, and miR-17-92 clusters may also regulate OPC differentiation in humans.
“Taken together, our data, along with the data obtained from inactive white matter lesions in multiple sclerosis (Junker et al., 2009) strongly suggests that miR-219, miR-338, and miR-17-92 clusters may also regulate OPC differentiation in humans.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Junker et al., 2009 source
- Interpretationreasoning
The miR-338 cluster has a conserved role in regulating OPC differentiation in humans.
“These findings suggest a conserved role for the miR-338 cluster in regulating OPC differentiation in humans.”
Quote in the paperSubstantial claim - Premisecitation
Regulation of miR-17-92 cluster expression during the OPC/OL transition was not reported in previous microarray studies.
“In previous microarray studies, regulation of miR-17-92 cluster expression during the OPC/OL transition was not reported (Lau et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lau et al., 2008 source
Not checked in the free run.
- Interpretationown data
This cluster is OPC/OL enriched.
“In addition, the expression profile of miR-17-92 cluster members during OPC differentiation in vitro is very similar to the profile seen in the developing mouse brain (Figure 4B), suggesting that this cluster is OPC/OL enriched.”
Quote in the paperSubstantial claim - Interpretationreasoning
The miR-17-92 cluster may be designated as an OL enriched miR in rodents.
“Thus the miR-17-92 cluster may be designated as an OL enriched miR in rodents.”
Quote in the paperSubstantial claim - Interpretationcitation
These miRs play important roles during myelination.
“In these studies, over-expression of miR-219-5p, miR-338-5p, and miR-338-3p was shown to promote rodent OPC differentiation, indicating that these miRs play important roles during myelination (Lau et al., 2008; Budde et al., 2010; Dugas et al., 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
Both studies show that the miR-17-92 cluster is abundantly expressed by human OLs.
“Despite the use of different techniques, both studies show that the miR-17-92 cluster is abundantly expressed by human OLs (Figure 4; Table 1).”
Quote in the paperSubstantial claim - Interpretationcitation
This data is consistent with the finding that the miR-17-92 cluster is enriched in OPCs rather than in astrocytes.
“This data is consistent with the finding that the miR-17-92 cluster is enriched in OPCs rather than in astrocytes (Budde et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Budde et al., 2010 source
- Interpretationown data
These miRs also play some specialized role in the postnatal brain.
“Intriguingly, at P21, a significant upregulation from levels at P7 is seen for all miRs except miR-92a-3p, suggesting that these miRs also play some specialized role in the postnatal brain.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 6
- May combine two claims. 16
Classified as probably not a substantial claim.
PremisecitationExpression profiling studies with rodent OLs have reported that several miR species are dramatically regulated during OPC differentiation.
“Expression profiling studies with rodent OLs have reported that several miR species are dramatically regulated during OPC differentiation (Lau et al., 2008; Budde et al., 2010; Dugas et al., 2010).”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
Findingown datamiR-219-5p is dramatically upregulated during rat oligodendrocyte precursor cell differentiation in vitro, peaking at DIV5 (>6-fold higher than at DIV1) and dropping by DIV8, but remaining higher than at DIV1.
“Quantitative real-time RT-PCR shows that miR-219-5p is dramatically upregulated, peaking at DIV5 (>6-fold higher than at DIV1) and dropping by DIV8, but remaining higher than at DIV1 (Figure 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-338-5p and miR-338-3p are upregulated and miR-3065-5p is downregulated during rat OPC differentiation in vitro.
“Quantitative real-time PCR showing upregulation in miR-338-5p and -3p and downregulation of miR-3065-5p during rat OPC differentiation in vitro.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-219-1-3p and miR-219-2-3p are regulated during rodent oligodendrocyte precursor cell differentiation: miR-219-1-3p peaks at DIV5 but returns to DIV1 levels by DIV8, whereas miR-219-2-3p levels remain high through DIV5 to DIV8.
“Additionally, we found that miR-219-1-3p and 219-2-3p are regulated during rodent OPC differentiation: miR-219-1-3p peaks at DIV5, but returns to DIV1 levels by DIV8 whereas miR-219-2-3p levels remain high through DIV5 to DIV8.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-338-3p and miR-3065-5p were not detected by RT-PCR but were readily amplified using more sensitive real-time RT-PCR.
“Although miR-338-3p and miR-3065-5p were not detected by RT-PCR, both miRs were readily amplified using more sensitive real-time RT-PCR.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe miR-338 cluster is expressed by the human cell line MO3.13 and human A2B5+ OLs.
“Endpoint RT-PCR followed by polyacrylamide gel electrophoresis showing that miR-338 cluster is expressed by the human cell line MO3.13 and human A2B5+ OLs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-338-5p, miR-3065-5p, and miR-657 are expressed in A2B5+ cells.
“Using this method, we found that miR-338-5p, miR-1250, and miR-3065-5p are expressed in the MO3.13 cell line whereas miR-338-5p, miR-3065-5p, and miR-657 are expressed in A2B5+ cells (Figure 3F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere is a delayed 10-fold elevation in miR-338-3p expression at P21 and a 30-fold elevation at P60 compared to the levels at P1.
“Specifically, there is a delayed 10-fold elevation in miR-338-3p expression at P21 and a 30-fold elevation at P60 (compared to the levels at P1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamiR-219-5p and miR-338-5p and miR-338-3p are expressed by human OLs.
“Importantly, our study is the first to report that miR-219-5p and miR-338-5p and -3p are expressed by human OLs (Figures 2H and 3F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll miR-17-92 miRs are readily detectable by quantitative real-time RT-PCR in both A2B5+ and A2B5− OLs with no significant differences in expression levels between the two populations.
“All miR-17-92 miRs were readily detectable by quantitative real-time RT-PCR in both A2B5+ and A2B5− OLs with no significant differences in expression levels between the two populations (Figure 4G).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datamiR-17-92 members are expressed by MO3.13 cells and human A2B5+ OLs.
“Endpoint RT-PCR followed by polyacrylamide gel electrophoresis showing that miR-17-92 members are expressed by MO3.13 cells and human A2B5+ OLs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWhen compared to P1, levels at P7 are about 90% reduced and maintained at a similarly low level into adulthood.
“When compared to P1, levels at P7 are about 90% reduced and maintained at a similarly low level into adulthood (Figure 4B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll miRs are expressed in the human OPC cell line (MO3.13) and in acutely isolated A2B5+ OLs.
“We also used endpoint RT-PCR to study their expression in human OL lineage cells and found that all miRs are expressed in the human OPC cell line (MO3.13) and in acutely isolated A2B5+ OLs (Figure 4F).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataWhen cultured in the absence of mitogens, oligodendrocyte precursor cells downregulate precursor genes (NG2) and upregulate myelin genes (PLP, MAG, CGT).
“Prior to the miR expression analysis, we confirmed by endpoint RT-PCR and western blot that when cultured in the absence of mitogens, OPCs downregulate precursor genes (NG2) and upregulate myelin genes (PLP, MAG, CGT; Figure 2C).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe human brain has been examined for miR expression and miR-219-5p, miR-338-5p, miR-338-3p, and members of the miR-17-92 cluster have been reported to be expressed.
“The human brain has also been examined for miR expression and miR-219-5p, miR-338-5p, miR-338-3p, and members of the miR-17-92 cluster have been reported to be expressed (Barad et al., 2004; Sempere et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenmiRs demonstrated to be functionally relevant in rodents perform a conserved function and regulate the proliferation and differentiation of human OPCs.
“We propose that miRs demonstrated to be functionally relevant in rodents perform a conserved function and regulate the proliferation and differentiation of human OPCs.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationown dataThe same miRs controlling OPC differentiation in rodents (miR-219-5p and miR-338-5p and miR-338-3p) may also control OPC differentiation in humans.
“These findings open the possibility that the same miRs controlling OPC differentiation in rodents (miR-219-5p and miR-338-5p and -3p) may also control OPC differentiation in humans.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationSome miR-17-92 members (miR-17-5p, 18a-5p, 19a-3p, 20a-5p, 19b-3p, and 92a-3p) have been implicated in the regulation of OPC proliferation in rodents, but their expression during postnatal brain development and cultured OPC differentiation has not been addressed.
“Some of them (miR-17-5p, 18a-5p, 19a-3p, 20a-5p, 19b-3p, and 92a-3p, highlighted in red in Figure 4A) have been implicated in the regulation of OPC proliferation in rodents, but their expression during postnatal brain development and cultured OPC differentiation has not been addressed (Budde et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Budde et al., 2010 source
- Rests on an assumption: The miR-17-92 cluster encodes 12 different miRs in both humans and rodents.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThese miRs might play a role in regulating levels of housekeeping transcripts in OLs.
“Though most miR-17-92 cluster members are downregulated during OPC differentiation, relative expression analysis reveals that these miRs are the most highly expressed miRs in both precursor and mature OLs (Table 1), suggesting that these miRs might play a role in regulating levels of housekeeping transcripts in OLs.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The human white matter tissue obtained from surgical resections for intractable epilepsy is representative of normal human white matter.
“We obtained white matter tissue excised from surgical resections carried out to ameliorate non-tumor-related intractable epilepsy as previously described (Ruffini et al., 2004; Dhaunchak et al., 2010).”
The paper relies on this without support.
In humans, the miR-338 cluster encodes six different mature miRs (miR-338-5p, miR-338-3p, miR-3065-5p, miR-3065-3p, miR-657, and miR-1250) that are encoded by four independent loci.
“In humans, the miR-338 cluster encodes six different mature miRs (miR-338-5p, miR-338-3p, miR-3065-5p, miR-3065-3p, miR-657, and miR-1250) that are encoded by four independent loci (Figure 3A).”
The paper relies on this without support.
miR-657 and miR-1250 are specific to humans and have not been detected in rodents.
“Interestingly, these two miRs are specific to humans and have not been detected in rodents.”
The paper relies on this without support.
miR-338-5p and miR-338-3p were previously detected in mature rodent OLs but miR-3065 expression has not been demonstrated before.
“miRs 338-5p and 338-3p were previously detected in mature rodent OLs but miR-3065 expression has not been demonstrated before.”
The paper relies on this without support.
The miR-17-92 cluster encodes 12 different miRs in both humans and rodents.
“The miR-17-92 cluster encodes 12 different miRs in both humans and rodents.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-338-3p was approximately 25-fold more abundant in oligodendrocytes than MNs.
“As expected, miR-338-3p, a miRNA known to be enriched in oligodendrocytes, was ϳ25-fold more abundant in oligodendrocytes than MNs (Zhao et al., 2010;de Faria et al., 2012) (Fig. 2D).”
From MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models (2017) · cites this paper as de Faria et al., 2012
The Results (section “Regulation of the miR-338 cluster during OPC differentiation,” Figure 3E) report that miR-338-3p is enriched in white matter, and the Discussion (“miR regulation in human OLs”) reports its expression in human oligodendrocytes. The source does not compare oligodendrocytes with motor neurons or report a 25-fold difference between them; the citing sentence points to its own Figure 2D for that measurement. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Human-specific miRs are also claimed to be expressed in rodent OLs
MinorThe abstract says the listed miRs, including miR-1250 and miR-657, are expressed in both rodent and human OLs. The Results instead describe miR-1250 and miR-657 as human-specific and not detected in rodents.
“we report the expression of closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, miR-3065-3p) in both rodent and human OLs.”
“Interestingly, these two miRs are specific to humans and have not been detected in rodents.”
First-time claim conflicts with earlier account of miR-338-3p regulation
MinorThe Discussion claims this study demonstrates regulation of miR-338-3p during rodent OPC differentiation for the first time, but the Introduction says earlier work found it more highly expressed in OLs than in precursors.
“we for the first time demonstrate that closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-338-3p, and miR-3065-5p) are also regulated during rodent OPC differentiation.”
“miRs 219-5p, 338-5p, and 338-3p are among the most highly expressed miRs in GalC+ OLs when compared to A2B5+ precursors (Lau et al., 2008).”
Cites
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462 · see citing works
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,931 · see citing works
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023 · see citing works
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,520 · see citing works
Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J. J., Bronson, R. T., Crowley, D. G., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,592 · see citing works
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578 · see citing works
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511 · see citing works
Winer, J., Jung, C. K. S., Shackel, I., & Williams, P. M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4085 · Cited by 1,388 · see citing works
Kessaris, N., Fogarty, M., Iannarelli, P., Grist, M., Wegner, M., & Richardson, W. D. (2006) · Nature Neuroscience · doi:10.1038/nn1620 · Cited by 1,195 · see citing works
Schmittgen, T. D., Zakrajsek, B. A., Mills, A., Gorn, V. V., Singer, M. J., & Reed, M. W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4753 · Cited by 1,036 · see citing works
Ota, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y., & Seto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3773 · Cited by 724 · see citing works
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668 · see citing works
Regulation of oligodendrocyte differentiation and myelination
Emery, B. (2010) · Science · doi:10.1126/science.1190927 · Cited by 653 · see citing works
Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., & Meinl, E. (2009) · Brain · doi:10.1093/brain/awp300 · Cited by 595 · see citing works
Real-time PCR quantification of precursor and mature microRNA
Schmittgen, T. D., Lee, E. J., Jiang, J., Sarkar, A., Yang, L., Elton, T. S., & Chen, C. (2008) · Methods · doi:10.1016/j.ymeth.2007.09.006 · Cited by 535 · see citing works
Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., & Barres, B. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.027 · Cited by 527 · see citing works
Windrem, M. S., Nunes, M. C., Rashbaum, W. K., Schwartz, T. H., Goodman, R. A., McKhann, G., Roy, N. S., & Goldman, S. A. (2004) · Nature Medicine · doi:10.1038/nm974 · Cited by 451 · see citing works
Barad, O., Meiri, E., Avniel, A., Aharonov, R., Barzilai, A., Bentwich, I., Einav, U., Gilad, S., Hurban, P., Karov, Y., et al. (2004) · Genome Research · doi:10.1101/gr.2845604 · Cited by 445 · see citing works
MicroRNA-Mediated Control of Oligodendrocyte Differentiation
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.-S., Xin, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.018 · Cited by 443 · see citing works
Matsubara, H., Takeuchi, T., Nishikawa, E., Yanagisawa, K., Hayashita, Y., Ebi, H., Yamada, H., Suzuki, M., Nagino, M., Nimura, Y., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210425 · Cited by 370 · see citing works
MicroRNA expression profiling of single whole embryonic stem cells
Tang, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gnj009 · Cited by 335 · see citing works
Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes
Lau, P., Verrier, J. D., Nielsen, J. A., Johnson, K. R., Notterpek, L., & Hudson, L. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1932-08.2008 · Cited by 252 · see citing works
miR-23regulation of lamin B1 is crucial for oligodendrocyte development and myelination
Lin, S., & Fu, Y. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001065 · Cited by 169 · see citing works
Control of oligodendroglial cell number by the miR-17-92 cluster
Budde, H., Schmitt, S., Fitzner, D., Opitz, L., Salinas-Riester, G., & Simons, M. (2010) · Development · doi:10.1242/dev.050633 · Cited by 128 · see citing works
McLaurin, J., Trudel, G. C., Shaw, I. T., Antel, J. P., & Cashman, N. R. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260212 · Cited by 114 · see citing works
Self-citationMicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells
Letzen, B. S., Liu, C., Thakor, N. V., Gearhart, J. D., All, A. H., & Kerr, C. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010480 · Cited by 107 · see citing works
Isolation and Characterization of Immature Oligodendrocyte Lineage Cells
Armstrong, R. C. (1998) · Methods · doi:10.1006/meth.1998.0685 · Cited by 82 · see citing works
Dhaunchak, A. S., & Nave, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704975104 · Cited by 80 · see citing works
Self-citationRegulation of oligodendrocyte differentiation
Goldman, J. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90179-c · Cited by 72 · see citing works
Dhaunchak, A. S., Colman, D., & Nave, K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2097-11.2011 · Cited by 68 · see citing works
Self-citationDistinctive Properties of Human Adult Brain-Derived Myelin Progenitor Cells
Ruffini, F., Arbour, N., Blain, M., Olivier, A., & Antel, J. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63266-x · Cited by 62 · see citing works
Self-citationResponse of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals
Cui, Q., Fragoso, G., Miron, V. E., Darlington, P. J., Mushynski, W. E., Antel, J. P., & Almazán, G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ef3be4 · Cited by 48 · see citing works
Self-citationA proteome map of axoglial specializations isolated and purified from human central nervous system
Dhaunchak, A. S., Huang, J. K., de Faria, O., Roth, A. D., Pedraza, L., Antel, J. P., Bar‐Or, A., & Colman, D. (2010) · Glia · doi:10.1002/glia.21064 · Cited by 48 · see citing works
Self-citationOligodendrocytes and the “Micro Brake” of Progenitor Cell Proliferation
Nave, K. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.026 · Cited by 36 · see citing works
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Flagged first, then by citations
Cited by
Sorted by citations
Pusic, A. D., & Kraig, R. P. (2013) · Glia · doi:10.1002/glia.22606 · Cited by 242 · see citing works
Smalheiser, N. R., Lugli, G., Zhang, H., Rizavi, H. S., Cook, E. H., & Dwivedi, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086469 · Cited by 195 · see citing works
Madsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0211-16.2016 · Cited by 161 · see citing works
Hsu, C., Hsieh, T., Tsai, C., Tsai, H., Chen, H., Chang, Y., Chuang, H., Lee, J.-N., Hsu, Y., & Tsai, E. (2013) · The Journal of Pathology · doi:10.1002/path.4295 · Cited by 157 · see citing works
Chamling, X., Kallman, A., Fang, W., Berlinicke, C. A., Mertz, J. L., Devkota, P., Pantoja, I. E. M., Smith, M. D., Ji, Z., Chang, C. K. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20892-3 · Cited by 99 · see citing works
MicroRNA dysregulation in multiple sclerosis
de Faria, O., Moore, C. S., Kennedy, T. E., Antel, J. P., Bar‐Or, A., & Dhaunchak, A. S. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00311 · Cited by 94 · see citing works
Self-citationMa, K., Xu, H., Zhang, J., Zhao, F., Liang, H., Sun, H., Li, P., Zhang, S., Wang, R., & Chen, X. (2019) · Aging · doi:10.18632/aging.102568 · Cited by 86 · see citing works
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models
Hoye, M. L., Koval, E. D., Wegener, A. J., Hyman, T. S., Yang, C., O'Brien, D. R., Miller, R. L., Cole, T., Schoch, K. M., Shen, T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3582-16.2017 · Cited by 82 · see citing works
Osorio-Querejeta, I., Carregal‐Romero, S., Ayerdi-Izquierdo, A., Mäger, I., Nash, L. A., Wood, M. J. A., Egimendia, A., Betanzos, M., Alberro, A., Iparraguirre, L., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020186 · Cited by 82 · see citing works
Gorris, R., Fischer, J., Erwes, K. L., Kesavan, J., Peterson, D. A., Alexander, M., Nöthen, M. M., Peitz, M., Quandel, T., Karus, M., et al. (2015) · Glia · doi:10.1002/glia.22882 · Cited by 64 · see citing works
Fan, H., Chen, L.-X., Qu, X., Ren, C., Wu, X., Dong, F., Zhang, B., Gao, D., & Yao, R. (2017) · Scientific Reports · doi:10.1038/srep41407 · Cited by 62 · see citing works
miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation
Galloway, D. A., & Moore, C. S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00059 · Cited by 59 · see citing works
Identification of common carp (Cyprinus carpio) microRNAs and microRNA-related SNPs
Zhu, Y., Xue, W., Wang, J.-T., Wan, Y.-M., Wang, S., Xu, P., Zhang, Y., Li, J.-T., & Sun, X. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-413 · Cited by 56 · see citing works
Liu, S., Ren, C., Qu, X., Wu, X., Dong, F., Chand, Y. K., Fan, H., Yao, R., & Geng, D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13485 · Cited by 52 · see citing works
Heterogeneity of oligodendrocyte progenitor cells in adult human brain
Leong, S. Y., Rao, V. T. S., Bin, J. M., Gris, P., Sangaralingam, M., Kennedy, T. E., & Antel, J. P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.55 · Cited by 50 · see citing works
Self-citationPlasma microRNA expression profiles in Chinese patients with rheumatoid arthritis
Wang, W., Zhang, Y., Zhu, B., Duan, T., Xu, Q., Wang, R., Lu, L., & Jiao, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.6449 · Cited by 50 · see citing works
de Faria, O., Dhaunchak, A. S., Kamen, Y., Roth, A. D., Kuhlmann, T., Colman, D., & Kennedy, T. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-40342-x · Cited by 47 · see citing works
Self-citationExtrinsic and Intrinsic Regulation of Axon Regeneration by MicroRNAs after Spinal Cord Injury
Li, P., Teng, Z., & Liu, C. (2016) · Neural Plasticity · doi:10.1155/2016/1279051 · Cited by 45 · see citing works
Lei, H., Zou, D., Li, Z., Luo, M., Dong, L., Wang, B., Yin, H., Ma, Y., Liu, C., Wang, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060369 · Cited by 43 · see citing works
RetractedKurachi, M., Mikuni, M., & Ishizaki, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159158 · Cited by 38 · see citing works
Lewkowicz, P., Ćwiklińska, H., Mycko, M. P., Cichalewska, M., Domowicz, M., Lewkowicz, N., Jurewicz, A., & Selmaj, K. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4794-14.2015 · Cited by 37 · see citing works
Osorio-Querejeta, I., Alberro, A., Muñoz‐Culla, M., Mäger, I., & Otaegui, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00434 · Cited by 37 · see citing works
Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning
Kleijn, K. M. A. D., Zuure, W. A., Peijnenborg, J., Heuvelmans, J. M., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8091096 · Cited by 34 · see citing works
MicroRNA and transcriptional crosstalk in myelinating glia
Svaren, J. P. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.06.010 · Cited by 33 · see citing works
Monfared, M., Nasirinezhad, F., Ebrahimi‐Barough, S., Hassanzade, G., Saberi, H., Tavangar, S. M., Asadpour, S., Aryan, L., Barabadi, Z., & Ai, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28527 · Cited by 32 · see citing works
How interacting pathways are regulated by miRNAs in breast cancer subtypes
Cava, C., Colaprico, A., Bertoli, G. R., Bontempi, G., Mauri, G., & Castiglioni, I. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1196-1 · Cited by 29 · see citing works
Nazari, B., Soleimani, M., Ebrahimi-Barough, S., Enderami, S. E., Kazemi, M., Negahdari, B., Sadroddiny, E., & Ai, J. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.03.001 · Cited by 24 · see citing works
Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination
Galloway, D. A., Gowing, E., Setayeshgar, S., & Kothary, R. (2019) · Glia · doi:10.1002/glia.23711 · Cited by 22 · see citing works
The epigenetic landscape of oligodendrocyte lineage cells
Selcen, I., Prentice, E., & Casaccia, P. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14959 · Cited by 20 · see citing works
Mazloumfard, F., Mirian, M., Eftekhari, S. M., & Aliomrani, M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00609-z · Cited by 19 · see citing works
MicroRNAs participate in the regulation of oligodendrocytes development in white matter injury
Xiao, D., Qu, Y., Pan, L., Li, X., & Mu, D. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0019 · Cited by 17 · see citing works
Qiu, S., Dai, H., Wang, Y., Lv, Y., Yu, B., & Yao, C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1404463 · Cited by 11 · see citing works
Nazari, B., Soleimanifar, F., Kazemi, M., Nazari, B., Enderami, S. E., Ai, A., Sadroddiny, E., Ebrahimi‐Barough, S., & Ai, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28248 · Cited by 8 · see citing works
Hippocampal sub-regional differences in the microRNA response to forebrain ischemia
Arvola, O., Kaidonis, G., Xu, L., Griffiths, B. B., & Stary, C. M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.05.003 · Cited by 8 · see citing works
Poisson, L. M., Kaur, N., Felicella, M. M., & Singh, J. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad144 · Cited by 8 · see citing works
Feng, T., Wang, L., Zhou, R., Yu, J., Wang, S., Deng, X., Zhang, W., Wang, B., Li, F., & Ma, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-86841-y · Cited by 7 · see citing works
Functions of noncoding RNAs in glial development
Wu, J., Yu, H., Huang, H., Shu, P., & Peng, X. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22848 · Cited by 6 · see citing works
A minor review of microRNA-338 exploring the insights of its function in tumorigenesis
Yi, Q., Cui, H., Liao, Y., Xiong, J., Ye, X., & Sun, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111720 · Cited by 6 · see citing works
Li, N., Liu, J., & Deng, X. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2808 · Cited by 5 · see citing works
Does rapid sequence divergence preclude RNA structure conservation in vertebrates?
Seemann, S. E., Mirza, A. H., Bang‐Berthelsen, C. H., Garde, C., Christensen‐Dalsgaard, M., Workman, C. T., Pociot, F., Tommerup, N., Gorodkin, J., & Ruzzo, W. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac067 · Cited by 4 · see citing works
Upadhayay, P., Sikka, R., & Gupta, H. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02745-x · Cited by 2 · see citing works
Paranode stability requires UNC5B expression by oligodendrocytesPreprint
de Faria, O., Nakamura, D. S., Clemot, S., Kim, D., Mocanu, M. V., Pilgram, R., Bin, J. M., Wong, E. W., Shmuel, A., Sadikot, A. F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.06.234906 · Cited by 2 · see citing works
Self-citationBasso, J., Sereno, J., Matos, A. M., Oliveira, R., Ramos, M. L., Castelo-Branco, M. S., Fortuna, A. C., Vitorino, R. M. P., & Vitorino, C. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102954 · Cited by 1 · see citing works
Profiling miRNAs Involved in Human Oligodendrocyte Precursor Cell Differentiation and Maturation
Barzegar, M., Dhukhwa, A., Patel, V. N., Velásquez, F. C., Das, S., Patil, A. H., Halushka, M. K., Zack, D. J., & Chamling, X. (2026) · Cells · doi:10.3390/cells15151343 · Cited by 1 · see citing works
Mechanisms of Plasticity, Remodeling and Recovery
Zhang, Z. G., & Chopp, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00011-6
Non-coding RNA and Multiple Sclerosis: New Targets for Drug Discovery
Osorio-Querejeta, I., Muñoz‐Culla, M., & Otaegui, D. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00285
Delivery of microRNAs as a remyelination strategy in multiple sclerosis.
Osorio-Querejeta, I. (2019) · Communities in ADDI (Universidad del Pais Vasco)
Agrawal, S., & Becker, C. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-28584-5_12
Li, N., Liu, J., & Deng, X. (2020) · doi:10.21203/rs.3.rs-29331/v1
Li, N., Liu, J., & Deng, X. (2020) · Research Square · doi:10.21203/rs.3.rs-49573/v1
Role of MeCP2 in oligodendrocyte lineage cells in Rett syndrome: review and inference
Zhang, Z., Li, P., & Chen, Y. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.13
Challenges in biomarker discovery research
Dhillon, S. K., Lear, B. A., King, V. J., Bennet, L., & Gunn, A. J. (2026) · Pediatric Research · doi:10.1038/s41390-026-05080-7
Natural flavonoids in multiple sclerosis: molecular insights and emerging therapeutic strategies
Abusaliya, A., Shamsi, M. A., Orsud, H., Rasbi, Z. A., Zoughbor, S. H., & Joher, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1888423
- Authors
- de Faria Jr., O., Cui, Q.-L., Bin, J. M., Bull, S.-J., Kennedy, T. E., Bar-Or, A., Antel, J. P., Colman, D. R., & Dhaunchak, A. S.
- Affiliations
- Montreal Neurological Institute and Hospital (CA)
- Corresponding author
- Dhaunchak, Ajit S.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 46-46
- ISSN
- 1664-8021 (ISSN-L)
- PMC
- PMC3314186
- OpenAlex
- W2074103481
- Semantic Scholar
- f392f33ecf27be49505886df41bd2cd8c93e5140
- Cited by
- 54
- References
- 35
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 9 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Frontiers in Genetics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Molson Foundation
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- microRNA, miR-219, miR-338, miR-17-92 cluster, oligodendrocyte precursor cells, oligodendrocyte lineage, myelination, miRNA expression profiling, demyelinating disease, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-06.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review